AUB ScholarWorks

Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation

Show simple item record

dc.contributor.author Antar A.
dc.contributor.author Otrock Z.K.
dc.contributor.author Kharfan-Dabaja M.
dc.contributor.author Salem Z.
dc.contributor.author Aractingi S.
dc.contributor.author Mohty M.
dc.contributor.author Bazarbachi A.
dc.contributor.editor
dc.date Jul-2013
dc.date.accessioned 2017-10-05T15:40:11Z
dc.date.available 2017-10-05T15:40:11Z
dc.date.issued 2013
dc.identifier 10.1038/bmt.2012.256
dc.identifier.isbn
dc.identifier.issn 02683369
dc.identifier.uri http://hdl.handle.net/10938/17293
dc.description.abstract [No abstract available]
dc.format.extent
dc.format.extent Pages: (994-995)
dc.language English
dc.publisher LONDON
dc.relation.ispartof Publication Name: Bone Marrow Transplantation; Publication Year: 2013; Volume: 48; no. 7; Pages: (994-995);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation
dc.type Letter
dc.contributor.affiliation Antar, A., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Otrock, Z.K., Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States
dc.contributor.affiliation Kharfan-Dabaja, M., Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, United States
dc.contributor.affiliation Salem, Z., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.affiliation Aractingi, S., Department of Dermatology, Tenon Hospital, APHP and Paris 6 University, Paris, France
dc.contributor.affiliation Mohty, M., Hematologie Clinique, Université de Nantes, INSERM CRNCA UMR892, Nantes, France
dc.contributor.affiliation Bazarbachi, A., Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.authorAddress Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail bazarbac@aub.edu.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Antar, A
dc.contributor.authorInitials Otrock, ZK
dc.contributor.authorInitials Kharfan-Dabaja, M
dc.contributor.authorInitials Salem, Z
dc.contributor.authorInitials Aractingi, S
dc.contributor.authorInitials Mohty, M
dc.contributor.authorInitials Bazarbachi, A
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Antar, A (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Bekassy AN, 1996, BONE MARROW TRANSPL, V17, P801; Berthou C, 1998, LEUKEMIA, V12, P1676, DOI 10.1038-sj.leu.2401144; Cunningham I, 2006, LEUKEMIA LYMPHOMA, V47, P1754, DOI 10.1080-10428190600632857; de Lima M, 2010, CANCER-AM CANCER SOC, V116, P5420, DOI 10.1002-cncr.25500; FRASSONI F, 1988, BRIT J HAEMATOL, V70, P317, DOI 10.1111-j.1365-2141.1988.tb02488.x; Koc Y, 1999, CANCER, V85, P608, DOI 10.1002-(SICI)1097-0142(19990201)85:3608::AID-CNCR113.0.CO;2-5; Lee KH, 2003, BONE MARROW TRANSPL, V32, P835, DOI 10.1038-sj.bmt.1704223; Platzbecker U, 2012, LEUKEMIA, V26, P381, DOI 10.1038-leu.2011.234; Savani BN, 2009, BONE MARROW TRANSPL, V44, P769, DOI 10.1038-bmt.2009.300; Serrao A, LEUK LYMPHOMA
dc.description.citedCount 1
dc.description.citedTotWOSCount 1
dc.description.citedWOSCount 1
dc.format.extentCount 2
dc.identifier.articleNo
dc.identifier.coden BMTRE
dc.identifier.pubmedID 23292243
dc.identifier.scopusID 84880223535
dc.identifier.url
dc.publisher.address MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Bone Marrow Transplant.
dc.relation.ispartOfIssue 7
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Bone Marrow Transplantation
dc.relation.ispartofPubTitleAbbr Bone Marrow Transplant.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 48
dc.source.ID WOS:000321302300020
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS azacitidine, 320-67-2, 52934-49-3
dc.subject.otherChemCAS cladribine, 4291-63-8
dc.subject.otherChemCAS cytarabine, 147-94-4, 69-74-9
dc.subject.otherChemCAS fludarabine, 21679-14-1
dc.subject.otherChemCAS idarubicin, 57852-57-0, 58957-92-9
dc.subject.otherChemCAS Antimetabolites, Antineoplastic
dc.subject.otherChemCAS Azacitidine, M801H13NRU
dc.subject.otherIndex azacitidine
dc.subject.otherIndex cladribine
dc.subject.otherIndex cytarabine
dc.subject.otherIndex fludarabine
dc.subject.otherIndex gemtuzumab ozogamicin
dc.subject.otherIndex granulocyte colony stimulating factor
dc.subject.otherIndex idarubicin
dc.subject.otherIndex abdominal mass
dc.subject.otherIndex acute granulocytic leukemia
dc.subject.otherIndex acute monocytic leukemia
dc.subject.otherIndex adult
dc.subject.otherIndex allogeneic hematopoietic stem cell transplantation
dc.subject.otherIndex blood toxicity
dc.subject.otherIndex bone marrow examination
dc.subject.otherIndex cancer combination chemotherapy
dc.subject.otherIndex cancer prognosis
dc.subject.otherIndex cancer radiotherapy
dc.subject.otherIndex case report
dc.subject.otherIndex clinical feature
dc.subject.otherIndex computer assisted tomography
dc.subject.otherIndex drug dose reduction
dc.subject.otherIndex drug effect
dc.subject.otherIndex drug megadose
dc.subject.otherIndex drug tolerability
dc.subject.otherIndex erythema
dc.subject.otherIndex female
dc.subject.otherIndex gingiva hypertrophy
dc.subject.otherIndex granulocytic sarcoma
dc.subject.otherIndex human
dc.subject.otherIndex human tissue
dc.subject.otherIndex letter
dc.subject.otherIndex leukemia relapse
dc.subject.otherIndex low drug dose
dc.subject.otherIndex maculopapular rash
dc.subject.otherIndex male
dc.subject.otherIndex multiple cycle treatment
dc.subject.otherIndex priority journal
dc.subject.otherIndex salvage therapy
dc.subject.otherIndex skin biopsy
dc.subject.otherIndex skin nodule
dc.subject.otherIndex treatment duration
dc.subject.otherIndex tumor volume
dc.subject.otherIndex Adult
dc.subject.otherIndex Antimetabolites, Antineoplastic
dc.subject.otherIndex Azacitidine
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Leukemia, Myeloid, Acute
dc.subject.otherIndex Male
dc.subject.otherIndex Mouth Neoplasms
dc.subject.otherIndex Recurrence
dc.subject.otherIndex Skin Neoplasms
dc.subject.otherKeywordPlus BONE-MARROW-TRANSPLANTATION
dc.subject.otherKeywordPlus ACUTE-LEUKEMIA
dc.subject.otherWOS Biophysics
dc.subject.otherWOS Oncology
dc.subject.otherWOS Hematology
dc.subject.otherWOS Immunology
dc.subject.otherWOS Transplantation


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account